Mutations in Stra6 are associated with severe developmental defects (Pasutto et al., 2007) and diseases such as diabetes (Chen, C. H. et al., 2019); however, there are no records in ChEMBL or PubChem for STRA6 nor literature connecting it with drug therapies or chemical toxicity. Here, STRA6 is linked to diabetes mellitus.